{
  "id": 3368124,
  "title": "Revvity Stock: Is Wall Street Bullish or Bearish?",
  "url": "https://urgent.news/2026/08/24/revvity-stock-is-wall-street-bullish-or-bearish",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-24T14:30:03.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/revvity-stock-wall-street-bullish-143003277.html"
  },
  "original_language": "en",
  "account": "Revvity, Inc. (RVTY), a Massachusetts-based health sciences solutions provider, has demonstrated strong performance in the stock market. With a market capitalization of $13.9 billion, the company specializes in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and more. Shares of RVTY have outperformed the broader market, gaining 39.1% over the past year compared to the S&P 500 Index's 20.5% rise. Furthermore, RVTY's stock rose 28.9% in 2026, surpassing the S&P 500's 12.1% increase on a year-to-date basis. Notably, RVTY has outperformed not only the S&P 500 but also the State Street Health Care Select Sector SPDR ETF (XLV), which gained 27.4% and 12.8% YTD, respectively. The company's success can be attributed to its strong performance in diagnostics, driven by reproductive health, ex-China immunodiagnostics, newborn screening, and AI-driven demand. Additionally, RVTY exited its China immunodiagnostics business and reinvested tariff refunds into capacity and innovation. Analysts have a generally moderate outlook, with six \"Strong Buy\" ratings and eleven \"Hold\" ratings, resulting in a consensus of \"Moderate Buy.\" JPMorgan Chase & Co. analyst Casey Woodring maintains a \"Hold\" rating with a price target of $110, but the Street-high target of $145 indicates a potential 16.2% upside.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}